About EMIP-FR and reperfusion damage in AMI: a comment to the comment

Comment

M Marzilli et al. Eur Heart J. 2001 Jun.

. 2001 Jun;22(11):973-5; author reply 978.

doi: 10.1053/euhj.2000.2489.

No abstract available

Comment on

Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine.
Kober G, Buck T, Sievert H, Vallbracht C. Kober G, et al. Eur Heart J. 1992 Aug;13(8):1109-15. doi: 10.1093/oxfordjournals.eurheartj.a060322. Eur Heart J. 1992. PMID: 1505561 Clinical Trial.
Acute myocardial infarction: new protagonists and new challenges.
Marzilli M, Mariani M. Marzilli M, et al. Eur Heart J. 1999 Dec;20(23):1691-2. doi: 10.1053/euhj.1999.1826. Eur Heart J. 1999. PMID: 10562475 Review. No abstract available.
Decreased no-reflow in patients with anterior myocardial infarction and pre-infarction angina.
Karila-Cohen D, Czitrom D, Brochet E, Faraggi M, Seknadji P, Himbert D, Juliard JM, Assayag P, Steg PG. Karila-Cohen D, et al. Eur Heart J. 1999 Dec;20(23):1724-30. doi: 10.1053/euhj.1999.1714. Eur Heart J. 1999. PMID: 10562480
The EMIP project. European Myocardial Infarction Project.
Tognoni G. Tognoni G. Eur Heart J. 2000 Sep;21(18):1498-9. doi: 10.1053/euhj.2000.2230. Eur Heart J. 2000. PMID: 10973762 No abstract available.
Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
[No authors listed] [No authors listed] Eur Heart J. 2000 Sep;21(18):1537-46. doi: 10.1053/euhj.1999.2439. Eur Heart J. 2000. PMID: 10973768 Clinical Trial.